Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly | Vienna | Healthcare | Pharmaceuticals | EUR 765.38B | 114x | 8.72 | EUR 843.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novo Nordisk AS | Vienna | Healthcare | Pharmaceuticals | EUR 488.03B | 40.6x | 1.16 | EUR 110 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Johnson & Johnson | Vienna | Healthcare | Pharmaceuticals | EUR 355.78B | 10.4x | 0.11 | EUR 148.42 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abbvie | Vienna | Healthcare | Pharmaceuticals | EUR 314.68B | 64.9x | -1.68 | EUR 177.72 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck & Co | Vienna | Healthcare | Pharmaceuticals | EUR 253.27B | 20.3x | 0.06 | EUR 99.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AstraZeneca DRC | Vienna | Healthcare | Pharmaceuticals | EUR 220.60B | 37.3x | 8.67 | EUR 70.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amgen | Vienna | Healthcare | Pharmaceuticals | EUR 160.17B | 56.2x | -0.92 | EUR 296.20 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pfizer | Vienna | Healthcare | Pharmaceuticals | EUR 150.69B | -63.4x | 0.57 | EUR 27.42 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sanofi | Vienna | Healthcare | Pharmaceuticals | EUR 127.15B | 14.3x | -0.58 | EUR 100.58 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gilead Sciences | Vienna | Healthcare | Pharmaceuticals | EUR 96.36B | 100.3x | -1.24 | EUR 77.50 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zoetis | Vienna | Healthcare | Pharmaceuticals | EUR 79.07B | 37.1x | 4.95 | EUR 174.92 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck KGaA | Vienna | Healthcare | Pharmaceuticals | EUR 68.72B | 26x | -1.75 | EUR 156.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Takeda Pharmaceutical | Vienna | Healthcare | Pharmaceuticals | EUR 41.43B | 44.6x | -0.89 | EUR 26.12 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ucb SA | Vienna | Healthcare | Pharmaceuticals | EUR 32.93B | 138.1x | -4.89 | EUR 172.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biogen Inc | Vienna | Healthcare | Pharmaceuticals | EUR 25.23B | 23.6x | -0.42 | EUR 171.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Teva Pharmaceutical Industries DRC | Vienna | Healthcare | Pharmaceuticals | EUR 17.97B | -42.8x | -0.53 | EUR 15.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Viatris | Vienna | Healthcare | Pharmaceuticals | EUR 12.36B | -21.1x | 0.16 | EUR 10.39 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biomarin Pharma | Vienna | Healthcare | Pharmaceuticals | EUR 12.30B | 51.8x | 0.34 | EUR 64.18 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Recordati Industria Chimica e | Vienna | Healthcare | Pharmaceuticals | EUR 10.96B | 28.4x | -72.53 | EUR 53.30 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ipsen | Vienna | Healthcare | Pharmaceuticals | EUR 9.34B | 13.7x | 0.28 | EUR 114.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Grifols | Vienna | Healthcare | Pharmaceuticals | EUR 6.56B | 42.1x | 0.01 | EUR 9.77 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
H Lundbeck AS | Vienna | Healthcare | Pharmaceuticals | EUR 6.23B | 17.3x | 4.08 | EUR 5.37 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
H Lundbeck AS | Vienna | Healthcare | Pharmaceuticals | EUR 6.23B | 17.3x | 4.08 | EUR 6.51 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laboratorios Farmaceuticos ROVI | Vienna | Healthcare | Pharmaceuticals | EUR 3.83B | 26.3x | -1.39 | EUR 74.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bavarian Nordic AS | Vienna | Healthcare | Pharmaceuticals | EUR 2.23B | 23.4x | -0.61 | EUR 28.51 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Almirall | Vienna | Healthcare | Pharmaceuticals | EUR 1.91B | -50.2x | 0.21 | EUR 9.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biotest Pref | Vienna | Healthcare | Pharmaceuticals | EUR 1.65B | 7.9x | 0 | EUR 28 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tilray Brands | Vienna | Healthcare | Pharmaceuticals | EUR 1.31B | -6.1x | -0.08 | EUR 1.49 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharma Mar | Vienna | Healthcare | Pharmaceuticals | EUR 875.19M | -497.4x | 4.46 | EUR 48.66 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marinomed Biotech AG | Vienna | Healthcare | Pharmaceuticals | EUR 16.06M | EUR 8.88 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |